Search the Newsreel

Can Abbott Laboratories (ABT)’s Lingo Partnership With Alphabet (GOOG) Unlock a New Era of AI-Powered Health?

On August 11, medtech leader Abbott Laboratories (NYSE:ABT) and tech behemoth Alphabet Inc. (NASDAQ:GOOG) announced a multi-year partnership to unite continuous glucose monitoring with consumer AI. The collaboration embeds data from Abbott's non-prescription Lingo biowearable directly into the Google Health app, combining real-time metabolic …

JPMorgan Chase & Co. Has Lowered Expectations for BridgeBio Oncology Therapeutics (NASDAQ:BBOT) Stock Price

Die Abbott-Laboratories-Aktie legt nach starker Q2-Guidance moderat zu

Abbott Laboratories: Revenue and Earnings Analysts Forecasts Revisions | ABT | US0028241000

Abbott India Shares Fall Over 2%

Top Abbott Executive Makes Bold Move With Fresh Insider Stock Sale

An executive at Abbott Laboratories (ABT), Louis H. Morrone, recently sold 5,850 shares of company stock for $642,505. This insider transaction provides investors with additional data to consider regarding the company's current valuation. Abbott's stock performance and analyst ratings are influenced by its strong …

Abbott Laboratories (NYSE:ABT) Raised to Outperform at Wolfe Research

Wolfe Research upgraded Abbott Laboratories (NYSE:ABT) to "outperform" from "peer perform," setting a $130 price target, which suggests a 17.2% upside. This upgrade comes after Abbott's recent quarterly results surpassed expectations, with EPS of $1.31 and revenue of $12.59 billion, an increase of 13% …

What's Backing Abbott's Established Pharmaceuticals Division Growth

Abbott Laboratories' ABT Established Pharmaceuticals Division ("EPD") continues to be a solid growth contributor, supported by its broad portfolio of branded generic medicines and strong commercial presence across emerging markets. In the second quarter of 2026, EPD sales increased 8.4% on a reported basis …

Wolfe Research downgrades Stryker, upgrades Abbott in med-tech shuffle

Investing.com -- Wolfe Research made two rating changes across large-cap medical devices, downgrading Stryker while upgrading Abbott Laboratories on Thursday. Analyst Mike Polark cut Stryker to Peer Perform, citing a demanding second-half setup following the company's March cyber disruption. He said the June quarter …

Here Are Thursday’s Top Wall Street Analyst Research Calls: Abbott Labs, AbbVie, Akamai Technologies, Five Below, Keurig Dr. Pepper, Salesforce, Stryker, StubHub, and More

This article details Wall Street analyst upgrades, downgrades, and initiations for various companies on Thursday, August 13, 2026, following the release of inline CPI data. Key movements include Five Below being upgraded to Buy at Jefferies and StubHub being cut to Underperform at Bank …

Die Abbott-Laboratories-Aktie legt nach starken Quartalszahlen und solider Guidance zu

V. M. Manning & CO. Inc. Acquires New Position in Abbott Laboratories $ABT

V. M. Manning & CO. Inc. has acquired a new stake in Abbott Laboratories, purchasing 19,849 shares valued at approximately $1.8 million, making it their 11th largest holding. This move comes as Abbott Laboratories exceeded its quarterly earnings expectations and maintains a positive outlook …

McCollum Christoferson Group LLC Sells 62,644 Shares of Abbott Laboratories $ABT

Abbott India Q1 FY27 Results: Revenue Rs 1,813 Cr, PAT Rs 428 Cr and Key Highlights

Abbott India Shares Fall 2.03% to Rs 27,570; Among Top Losers on Nifty Midcap 150

Abbott Laboratories $ABT Shares Acquired by DAVENPORT & Co LLC

Abbott Laboratories Aktie | US0028241000 | ETR:ABL | News & Aktienkurs | FRA:ABL

Rep. Mike Kelly Unloads Abbott Laboratories (NYSE:ABT) Shares

Representative Mike Kelly sold shares of Abbott Laboratories (NYSE:ABT) valued between $1,001 and $15,000 on July 17th, as well as shares of PepsiCo and Walt Disney on the same day. This sale occurred despite Abbott Laboratories reporting a quarterly earnings beat and reaffirming its …

Mike Kelly makes multiple trades including Abbott Laboratories and Disney stocks

Congressman Mike Kelly recently executed several trades through the Victoria Kelly Trust ICA, including selling stocks from Abbott Laboratories and The Walt Disney Company, each valued between $1,001 and $15,000. He also sold Pepsico, Inc. stocks worth $15,001 to $50,000. Additionally, Kelly purchased government …

Abbott Laboratories (ABT) Ties Lingo Glucose Data To AI Health Tools

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Abbott Laboratories (NYSE:ABT) and Google Health announced a multi year partnership to integrate Abbott's Lingo biowearable glucose data with Google's AI driven consumer health …

ABBOTT LABORATORIES AKTIE: AI-Analysen, Prognose & Kursziel

Abbott Laboratories stock outperforms competitors on strong trading day

Shares of Abbott Laboratories (ABT) rose 1.08% to $110.91, marking its third consecutive day of gains. This performance occurred on a mixed trading day where the S&P 500 Index increased by 0.26% and the Dow Jones Industrial Average fell by 0.04%. The stock's positive …

The Abbott Big Ten $1 Million Blood Drive is Back

The Abbott Big Ten $1 Million Blood Drive returns for its third year, with Nebraska aiming to reclaim the title from Wisconsin. The competition, which runs from August 26th to December 4th, encourages donations to help address a national blood crisis, with a $1 …

What Abbott Laboratories (ABT)'s AI-Powered Google Health Partnership Means For Shareholders

Abbott Laboratories has partnered with Google Health to integrate glucose insights from its Lingo biowearable into the Google Health app, using AI for personalized metabolic health coaching and unified wellness data. This collaboration includes a large-scale metabolic health study, potentially supporting Abbott's diabetes franchise …

Abbott India Q1 net profit surges 17% despite 4% revenue growth

Every 2 Seconds, Someone in the U.S. Needs Blood as Abbott Drive Returns

Abbott (NYSE: ABT) and the Big Ten Conference have relaunched their "We Give Blood" nationwide competition to address a critical blood supply crisis in the U.S. All 18 Big Ten universities will compete to generate the most blood donations, with Abbott awarding $1 million …

Abbott India Limited Reports Earnings Results for the First Quarter Ended June 30, 2026

Abbott and Big Ten bring back 'We Give Blood' as U.S. faces blood supply crisis

"We Give Blood" brings together all 18 Big Ten® schools in a competition to drive the most blood donations and win $1 million from global healthcare company Abbott For only the second time in its history, the American Red Cross has declared a national …

Abbott Laboratories $ABT Shares Sold by West Branch Capital LLC

West Branch Capital LLC significantly reduced its stake in Abbott Laboratories (NYSE:ABT) by 83.5% in the second quarter, selling 13,061 shares and retaining 2,576 shares worth $234,000. Despite this sell-off, institutional investors collectively own 75.18% of Abbott’s stock. Abbott reported strong Q2 earnings of …

Butensky & Cohen Financial Security Inc. Purchases 9,277 Shares of Abbott Laboratories $ABT

Butensky & Cohen Financial Security Inc. increased its stake in Abbott Laboratories (NYSE:ABT) by 26.9% in the second quarter, acquiring an additional 9,277 shares to own a total of 43,809 shares valued at $3.98 million. This move comes as Abbott Laboratories reported strong quarterly …

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories (NYSE:ABT) has received a consensus "Moderate Buy" rating from twenty-six brokerages, with an average 12-month price target of $118.17. The company recently exceeded quarterly expectations with adjusted EPS of $1.31 and revenue of $12.59 billion, and announced a quarterly dividend of $0.63 …

¿Puede Abbott Laboratories (ABT) Estar 8% Infravalorada Tras Mejorar Su Previsión Anual?

Abbott Laboratories (ABT) schedules NYSE sale of stock from vested awards

Abbott Laboratories (ABT) has filed a Form 144 indicating a planned sale of 5,850 common shares through UBS Financial Services on or after August 11, 2026, on the NYSE. The shares originate from vested restricted stock awards granted on February 27, 2026, totaling 1,960, …